Category: Gene Therapy
United States Gene Therapy
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2025: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
... vital insights that can help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and ... Read More
-
US AAV Contract Development and Manufacturing Organizations Market Size study, by Workflow (Upstream Processing, Downstream Processing), by Culture Type, by Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), by End-User Forecasts 2022-2032
... End-User Forecasts 2022-2032 US AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 201.14 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.85% over ... Read More
-
U.S. Cell And Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis Report By Service (Site Identification, Patient Recruitment), By Phase (Phase I, Phase II), By Therapeutic Areas, By Therapy Type, And Segment Forecasts, 2024 - 2030
... Forecasts, 2024 - 2030 U.S. Cell And Gene Therapy Clinical Trial Services Market Growth & Trends The U.S. cell and gene therapy clinical trial services market is expected to reach USD 28.58 billion by 2030, ... Read More
-
United States Regenerative Medicine Market By Type (Cell Therapies, Gene Therapies, Progenitor & Stem Cell Therapies, Tissue Engineered Products), By Material (Biologically Derived Material, Synthetic Material, Pharmaceuticals, Genetically Engineered Material), By Application (Musculoskeletal Disorders, Wound Care, Oncology, Ophthalmology, Neurology, Dermatology, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F
... Care, Oncology, Ophthalmology, Neurology, Dermatology, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F United States Regenerative Medicine Market is anticipated to project steady growth in the forecast period. Regenerative Medicine is an incredibly fascinating and ... Read More
-
US and Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral Vectors and Non-Viral Vectors)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country
... Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country The US and Europe cell and gene therapy manufacturing services market was valued at ... Read More
-
US Cell & Gene Therapy Market - Focused Insights 2023-2028
... & gene therapy products, such as conventional cell therapies, CAR-T cell therapies, gene therapies, cell-based immunotherapies, and oncolytic virus therapies. Cell therapies sourced from mesenchymal stem cells, cell-based immune modulation therapies, and cell/tissue-based products derived ... Read More
-
NA Gene Therapy Market - Industry Trends and Forecast to 2030
... Rare Diseases, Neurological Disorders, and Other Diseases), End User (Cancer Institutes, Hospitals, Research Institutes, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030. Market Definition Gene therapy is a medical strategy ... Read More
-
North America Pharmaceutical Excipients Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)
... Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and ... Read More
-
Biological Product (except Diagnostic) Manufacturing - 2023 U.S. Market Research Report with Updated COVID-19 & Recession Forecasts
... assessments of the industry in the United States with over 100 data sets covering 2014-2027. This report includes updated forecasts due to the economic impact of COVID-19 and a potential recession. This 39-page report is ... Read More
-
U.S. Degenerative Disc Disease Treatment Market, by Treatment (Epidural Steroid Injections, Narcotics (Morphine, Methadone Hydrochloride, Codeine, Hydrocodone, Tramodol, Oxycodone, and Others), Orthobiologics (Includes Biomolecular/Gene Therapy, Cell-base
... Phase III), by Disease Indication (Early Stage, Mid Stage, and Late Stage), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Degenerative disc ... Read More
-
U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027
... to the increased availability of funding from various public and private institutes. In addition, there is increased support from regulatory bodies for product approvals and providing fast-track designations to the products, which encourages vendors to ... Read More
Research Assistance
